Annual report pursuant to Section 13 and 15(d)

Equity (Tables)

v2.4.1.9
Equity (Tables)
 12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Schedule of Proceeds From Expenses Related Private Placement

The expenses related to this private placement are detailed below:

 

    $     $  
Gross Proceeds:             800,732  
Broker Commission     40,037          
Legal Fees     15,671          
Total Expenses             55,708  
Net Proceeds:             745,024  

Schedule of Proceeds from Initial Public Offering

The expenses related to this public offering are as follows:

 

    $     $  
Gross Proceeds:             14,998,500  
Underwriter/Aegis Expenses                
Underwriter Commission     1,049,895          
Underwriter Expenses     149,985          
Aegis Legal Fees     80,000          
Aegis Registration Expenses     7,500          
Aegis Miscellaneous Expenses     36,675          
Aegis Road Show Expenses     20,000          
Total             1,344,055  
Akers Biosciences Expenses                
Legal & Accounting Expenses     393,298          
Printing & Document Prep     62,101          
Registration Expenses     55,946          
Road Show Expenses     41,764          
Total             553,109  
Net Proceeds:             13,101,336  

Schedule of Reserved Shares of Common Stock

As of December 31, 2014 and 2013 the Company has reserved shares of its common stock as follows:

 

    2014     2013  
Reserves for:                
Outstanding Warrants     1,989       1,989  
2013 Stock Incentive Plan     175,000       -  
Total Reserves     176,989       1,989  

Schedule of Reconcilement of the Movement of Shares

The following is a reconcilement of the movement of shares of Series A Convertible Preferred stock (preferred stock) and common stock:

 

      Authorized     Issued  
      Preferred     Common     Preferred     Common  
      Stock     Stock     Stock     Stock  
Balance at December 31, 2012       50,000,000       500,000,000       10,000,000       1,278,948  
                                   
Preferred Shares Converted:                                  
November 15, 2013       -       -       (10,000,000 )     320,512  
Shares Cancelled:                                  
December 3, 2013       -       -       -       (58,515 )
Shares Issued:                                  
June 12, 2013       -       -       -       512,820  
December 23, 2013       -       -       -       114,072  
Balance at December 31, 2013       50,000,000       500,000,000       -       2,167,837  
                                   
Shares Issued:                                  
January 23, 2014       -       -       -       2,727,000  
August 15, 2014       -       -       -       60,000  
Balance at December 31, 2014       50,000,000       500,000,000       -       4,954,837